|
RREB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79700000000538E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.376400E-02 |
| Normal-vs-Stage2 |
1.841600E-04 |
| Normal-vs-Stage3 |
2.22870000010644E-07 |
| Normal-vs-Stage4 |
2.77300005180336E-09 |
| Stage1-vs-Stage2 |
2.665600E-02 |
| Stage1-vs-Stage3 |
7.78300000000565E-05 |
| Stage1-vs-Stage4 |
2.25249999985522E-07 |
| Stage2-vs-Stage3 |
5.750400E-01 |
| Stage2-vs-Stage4 |
1.049620E-01 |
| Stage3-vs-Stage4 |
2.033600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.22359999999733E-05 |
| Normal-vs-AfricanAmerican |
3.835000E-04 |
| Normal-vs-Asian |
9.741000E-01 |
| Caucasian-vs-AfricanAmerican |
4.567200E-01 |
| Caucasian-vs-Asian |
1.523000E-01 |
| AfricanAmerican-vs-Asian |
9.515600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75319999995427E-06 |
| Normal-vs-Female |
7.356000E-03 |
| Male-vs-Female |
7.040800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.415700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.362200E-03 |
| Normal-vs-Age(61-80Yrs) |
6.60350000014631E-07 |
| Normal-vs-Age(81-100Yrs) |
9.028000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.229400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.318000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.344800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.270370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.485600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.871600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.572000E-01 |
| Normal-vs-Grade 2 |
1.378460E-02 |
| Normal-vs-Grade 3 |
1.51020999999973E-05 |
| Normal-vs-Grade 4 |
4.97990537695614E-12 |
| Grade 1-vs-Grade 2 |
2.244300E-02 |
| Grade 1-vs-Grade 3 |
7.220800E-04 |
| Grade 1-vs-Grade 4 |
2.16780005057871E-09 |
| Grade 2-vs-Grade 3 |
1.078400E-02 |
| Grade 2-vs-Grade 4 |
2.50560017178714E-10 |
| Grade 3-vs-Grade 4 |
3.85379999999769E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.505220E-01 |
| Normal-vs-ccB subtype |
2.32790000054273E-07 |
| ccA subtype-vs-ccB subtype |
2.74369999997415E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.440600E-04 |
| Normal-vs-N1 |
2.995700E-03 |
| N0-vs-N1 |
1.745200E-01 |
|
|
